Literature DB >> 12439144

Effects of inhaled plasminogen activator on the balance between coagulation and fibrinolysis in traumatized pigs.

A-M B Münster1, L Rasmussen, J Sidelmann, J Ingemann Jensen, B Bech, J Gram.   

Abstract

A profibrinolytic state is normal in the alveoli, but this may change as a result of trauma, possibly leading to fibrin deposition, a characteristic of acute lung injury/acute respiratory distress syndrome. Therefore, the present study investigated in a double-blind, placebo-controlled manner the effect of severe trauma on the alveolar fibrinolytic/coagulation balance, and the effect here-upon of inhalation of single-chain urokinase plasminogen activator (scu-PA) in pigs. The study shows an increased concentration of scu-PA in the bronchoalveolar lavage fluid of the treated animals in association with an increased plasmin-dependent fibrinolytic activity without increased systemic fibrinolytic activity, the transient increase in the concentration of scu-PA in the plasma being minimal. In conclusion, the study shows that activatable scu-PA can be nebulized to the lower respiratory tract and can increase the alveolar fibrinolysis without any significant systemic effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439144     DOI: 10.1097/00001721-200210000-00003

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.

Authors:  Kathleen A Stringer; Meghan Tobias; John S Dunn; Jackie Campos; Zachary Van Rheen; Mitra Mosharraf; Rajiv Nayar
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07-29       Impact factor: 2.557

2.  Lack of durable protection against cotton smoke-induced acute lung injury in sheep by nebulized single chain urokinase plasminogen activator or tissue plasminogen activator.

Authors:  Satoshi Fukuda; Perenlei Enkhbaatar; Christina Nelson; Robert A Cox; Marla R Wolfson; Thomas H Shaffer; Robert O Williams; Soraya Hengsawas Surasarang; Sahakijpijarn Sawittree; Galina Florova; Andrey A Komissarov; Kathleen Koenig; Krishna Sarva; Harrison T Ndetan; Karan P Singh; Steven Idell
Journal:  Clin Transl Med       Date:  2018-06-18

3.  Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury.

Authors:  Cong Liu; Yana Ma; Zhenlei Su; Runzhen Zhao; Xiaoli Zhao; Hong-Guang Nie; Ping Xu; Lili Zhu; Mo Zhang; Xiumin Li; Xiaoju Zhang; Michael A Matthay; Hong-Long Ji
Journal:  Front Immunol       Date:  2018-08-20       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.